VGNT — Versigent Income Statement
0.000.00%
Last trade - 00:00- $2.00bn
- $1.97bn
- $8.82bn
Annual income statement for Versigent, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 8,015 | 8,832 | 8,309 | 8,818 |
| Cost of Revenue | ||||
| Gross Profit | 869 | 1,035 | 974 | 1,082 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 7,524 | 8,245 | 7,852 | 8,284 |
| Operating Profit | 491 | 587 | 457 | 534 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 505 | 596 | 473 | 540 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 452 | 452 | 434 | 546 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 454 | 423 | 408 | 528 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 454 | 423 | 408 | 528 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 7.35 | 6.73 | 7.29 | 8.67 |